Literature DB >> 17885760

[Current status and perspectives of ambulatory rheumatologic health care in Germany : economic structural conditions and motivation of rheumatologists].

T Mittendorf1, E Edelmann, J Kekow, U von Hinüber, W Müller-Brodmann, J-M Graf von der Schulenburg.   

Abstract

AIM: To gather information about current structures in rheumatologic ambulatory health care in Germany. Based on the results recommendations on future structures will be evaluated.
METHODS: Data collection and statistical analysis via a structured 10-page questionnaire answered by members of the German Association of Rheumatologists. Questions in this second part of the study related to two topics: economic factors and a subjective assessment of the health care structures by the participants.
RESULTS: Data from 197 ambulatory rheumatologists who participated in health care could be included in the analyses. Extensive and detailed data on economic issues surrounding ambulatory patient treatment and practice management from the perspective of ambulatory rheumatologists are presented (e.g., revenue, income, income differences between regions or practice size). In addition, perceptions of participating rheumatologists on future perspectives of patient treatment, health policy, and their own economical survival are reported.
CONCLUSIONS: As in other specialties there is a significant difference not only between the eastern and western regions in Germany but also between the north and the south looking at e.g., revenue, income, with rheumatologists in the east treating significantly more patients. Reasons for those differences are not only related to regional remuneration schemes or the number of patients with a private but statutory health insurance, but are also driven by the number of different services provided (e.g., own laboratory). Physicians perceptions towards their own future in rheumatology are generally positive. Scepticism was reported for the individual economic survival in ambulatory treatment and future changes in health policy.

Entities:  

Mesh:

Year:  2007        PMID: 17885760     DOI: 10.1007/s00393-007-0190-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

Review 1.  [Research in patient care in the rheumatology specialty network--what is the benefit for improving patient care?].

Authors:  A Zink; D Huscher; G Westhoff
Journal:  Z Rheumatol       Date:  2002-02       Impact factor: 1.372

2.  [Conceptual and methodological basics of cost assessments in rheumatology].

Authors:  J Ruof; J L Hülsemann; T Mittendorf; J-M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Z Rheumatol       Date:  2004-10       Impact factor: 1.372

3.  [Routine report on the medical rehabilitation of patients with musculoskeletal diseases].

Authors:  W H Jäckel; W Mau; A Zink; W Beyer; U Droste; M Engel; E Genth
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

4.  [National database documentation for collecting, controlling and quality assurance of new therapies in rheumatoid arthritis].

Authors:  A Zink
Journal:  Z Rheumatol       Date:  2001-12       Impact factor: 1.372

5.  Direct costs related to rheumatoid arthritis: the patient perspective.

Authors:  J L Hülsemann; T Mittendorf; S Merkesdal; S Handelmann; J-M von der Schulenburg; H Zeidler; J Ruof
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

6.  [Costs of ambulatory care for RA patients in Germany].

Authors:  Thomas Mittendorf; Sonja Merkesdal; Henning Zeidler; J-Matthias Graf von der Schulenburg; Jörg Ruof
Journal:  Med Klin (Munich)       Date:  2005-05-13

7.  Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required?

Authors:  Jörg Ruof; Jan L Huelsemann; Thomas Mittendorf; Silke Handelmann; J Matthias von der Schulenburg; Henning Zeidler; Rick Aultman; Sonja Merkesdal
Journal:  Arthritis Rheum       Date:  2004-10-15

Review 8.  [The National Database of the German Arthritis Centres--a 12 year balance].

Authors:  A Zink; D Huscher; M Schneider
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

9.  Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.

Authors:  D Huscher; S Merkesdal; K Thiele; H Zeidler; M Schneider; A Zink
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

10.  Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.

Authors:  J Ruof; J L Hülsemann; T Mittendorf; S Handelmann; J M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

View more
  2 in total

1.  [Updated results of a survey on outpatient healthcare structures in rheumatology].

Authors:  T Mittendorf
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

2.  [Outpatient rheumatologic treatment in Germany].

Authors:  E Edelmann
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.